Allogeneic haematopoietic stem cell transplantation resets T- and B-cell compartments in sickle cell disease patients.

B‐cell neogenesis T‐cell neogenesis allogeneic haematopoietic stem cell transplantation peripheral homeostasis sickle cell disease

Journal

Clinical & translational immunology
ISSN: 2050-0068
Titre abrégé: Clin Transl Immunology
Pays: Australia
ID NLM: 101638268

Informations de publication

Date de publication:
2022
Historique:
received: 23 05 2021
revised: 05 04 2022
accepted: 06 04 2022
entrez: 27 4 2022
pubmed: 28 4 2022
medline: 28 4 2022
Statut: epublish

Résumé

Allogeneic haematopoietic stem cell transplantation (allo-HSCT) is the only currently available curative treatment for sickle cell disease (SCD). Here, we comprehensively evaluated the reconstitution of T- and B-cell compartments in 29 SCD patients treated with allo-HSCT and how it correlated with the development of acute graft-versus-host disease (aGvHD). T-cell neogenesis was assessed by quantification of signal-joint and β-chain TCR excision circles. B-cell neogenesis was evaluated by quantification of signal-joint and coding-joint K-chain recombination excision circles. T- and B-cell peripheral subset numbers were assessed by flow cytometry. Before allo-HSCT (baseline), T-cell neogenesis was normal in SCD patients compared with age-, gender- and ethnicity-matched healthy controls. Following allo-HSCT, T-cell neogenesis declined but was fully restored to healthy control levels at one year post-transplantation. Peripheral T-cell subset counts were fully restored only at 24 months post-transplantation. Occurrence of acute graft-versus-host disease (aGvHD) transiently affected T- and B-cell neogenesis and overall reconstitution of T- and B-cell peripheral subsets. B-cell neogenesis was significantly higher in SCD patients at baseline than in healthy controls, remaining high throughout the follow-up after allo-HSCT. Notably, after transplantation SCD patients showed increased frequencies of IL-10-producing B-regulatory cells and IgM Our findings revealed that the T- and B-cell compartments were normally reconstituted in SCD patients after allo-HSCT. In addition, the increase of IL-10-producing B-regulatory cells may contribute to improve immune regulation and homeostasis after transplantation.

Identifiants

pubmed: 35474905
doi: 10.1002/cti2.1389
pii: CTI21389
pmc: PMC9035210
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e1389

Informations de copyright

© 2022 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

J Immunol. 2017 Jan 1;198(1):40-46
pubmed: 27994167
Biol Blood Marrow Transplant. 2010 Nov;16(11):1557-66
pubmed: 20546907
Blood. 1997 Feb 15;89(4):1288-98
pubmed: 9028952
J Exp Med. 2007 Mar 19;204(3):645-55
pubmed: 17312005
Haematologica. 2013 Oct;98(10):1600-8
pubmed: 23585532
Biol Blood Marrow Transplant. 2015 Mar;21(3):389-401.e1
pubmed: 25529383
Biol Blood Marrow Transplant. 2014 May;20(5):668-75
pubmed: 24462743
J Exp Med. 1998 Nov 2;188(9):1679-89
pubmed: 9802980
Immunol Lett. 2020 Aug;224:1-11
pubmed: 32437728
Nat Rev Dis Primers. 2018 Mar 15;4:18010
pubmed: 29542687
Blood. 2009 Jun 18;113(25):6477-84
pubmed: 19258596
Annu Rev Immunol. 2012;30:221-41
pubmed: 22224776
Front Pediatr. 2021 Jan 05;8:551170
pubmed: 33469520
Haematologica. 2020 Jan 31;105(2):273-283
pubmed: 31919091
Am J Hematol. 2011 Dec;86(12):1001-6
pubmed: 21953592
Blood. 2014 Oct 9;124(15):2459-62
pubmed: 25185266
JAMA. 1976 Sep 20;236(12):1376-7
pubmed: 989094
Tissue Antigens. 2012 Feb;79(2):83-9
pubmed: 22220718
Eur J Immunol. 2015 Jun;45(6):1868-79
pubmed: 25763868
Immunol Rev. 2019 Nov;292(1):164-179
pubmed: 31559645
Front Immunol. 2020 Jul 31;11:1341
pubmed: 32849495
Br J Haematol. 2015 May;169(4):574-83
pubmed: 25753210
Hematology. 2007 Feb;12(1):1-13
pubmed: 17364987
Lancet. 2017 Jul 15;390(10091):311-323
pubmed: 28159390
Blood. 2017 Mar 16;129(11):1548-1556
pubmed: 27965196
Hematol J. 2003;4(5):363-5
pubmed: 14502263
Am J Hematol. 2016 Sep;91(9):938-46
pubmed: 27237467
Clin Infect Dis. 2018 Aug 16;67(5):743-750
pubmed: 29490030
J Immunol. 2008 Sep 1;181(5):3684-9
pubmed: 18714044
Cell Cycle. 2007 Dec 1;6(23):2890-5
pubmed: 18156800
J Clin Invest. 2002 Jun;109(12):1587-98
pubmed: 12070306
Clin Immunol. 2008 Apr;127(1):14-25
pubmed: 18191619
J Autoimmun. 2016 Sep;73:64-72
pubmed: 27372914
N Engl J Med. 1984 Sep 20;311(12):780-3
pubmed: 6382010
Front Immunol. 2021 Apr 29;12:611795
pubmed: 33995344
PLoS One. 2011;6(8):e23164
pubmed: 21829713
Blood. 1991 Apr 1;77(7):1607-15
pubmed: 1672615
Pediatr Res. 2016 Feb;79(2):262-70
pubmed: 26492283
Eur J Haematol. 2014 Nov;93(5):377-83
pubmed: 24796940
Immunol Lett. 1993 Jul;37(1):77-81
pubmed: 7901154
J Infect Dis. 2006 Apr 15;193(8):1189-90
pubmed: 16544264
Nature. 2012 Nov 8;491(7423):264-8
pubmed: 23064231
J Immunol. 2009 Jun 15;182(12):7459-72
pubmed: 19494269
Am J Hematol. 1985 Dec;20(4):409-12
pubmed: 4073014
Blood. 2001 Mar 1;97(5):1458-66
pubmed: 11222394
J Immunol. 2019 Oct 15;203(8):2110-2120
pubmed: 31511354
Sci Rep. 2015 Dec 09;5:17822
pubmed: 26648000
Blood. 2004 Dec 1;104(12):3647-54
pubmed: 15191950
Am J Gastroenterol. 2005 Aug;100(8):1788-95
pubmed: 16086716
Indian J Med Res. 2011 Oct;134:532-7
pubmed: 22089617
Blood. 2008 Sep 1;112(5):1570-80
pubmed: 18725575
Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):E5281-9
pubmed: 26324941
Transplantation. 1974 Oct;18(4):295-304
pubmed: 4153799
Blood. 2013 Jun 13;121(24):4955-62
pubmed: 23652802
Blood Adv. 2018 Jan 23;2(2):126-141
pubmed: 29365321
Front Immunol. 2019 Jun 14;10:1368
pubmed: 31258536
Blood. 2016 Feb 18;127(7):801-9
pubmed: 26758915
Br J Haematol. 2019 Jul;186(2):286-299
pubmed: 30972754
Immunol Lett. 1992 Dec;34(3):207-11
pubmed: 1487307
J Immunol Res. 2020 Jan 08;2020:4585704
pubmed: 32411797
Lancet. 2011 Jul 2;378(9785):86-97
pubmed: 21474172
J Clin Invest. 1987 Feb;79(2):388-98
pubmed: 3805275
Immunity. 2004 Dec;21(6):757-68
pubmed: 15589165

Auteurs

Luciana Ribeiro Jarduli-Maciel (LR)

Graduate Program in Biosciences Applied to Pharmacy School of Pharmaceutical Sciences of Ribeirão Preto University of São Paulo Ribeirão Preto SP Brazil.
Center for Cell-Based Therapy Regional Blood Center of Ribeirão Preto University of São Paulo Ribeirão Preto SP Brazil.

Júlia Teixeira Cottas de Azevedo (JTC)

Center for Cell-Based Therapy Regional Blood Center of Ribeirão Preto University of São Paulo Ribeirão Preto SP Brazil.
Graduate Program in Basic and Applied Immunology Ribeirão Preto Medical School University of São Paulo Ribeirão Preto SP Brazil.

Emmanuel Clave (E)

Université de Paris INSERM UMR 1160 IRSL Paris France.

Thalita Cristina de Mello Costa (TCM)

Center for Cell-Based Therapy Regional Blood Center of Ribeirão Preto University of São Paulo Ribeirão Preto SP Brazil.
University Hospital of Ribeirão Preto Medical School University of São Paulo Ribeirão Preto SP Brazil.

Lucas Coelho Marlière Arruda (LCM)

Department of Clinical Science, Intervention and Technology Karolinska Institutet Stockholm Sweden.

Isabelle Fournier (I)

Laboratoire d'Immunologie et d'Histocompatibilité Hôpital Saint-Louis AP-HP Paris France.

Patrícia Vianna Bonini Palma (PVB)

Center for Cell-Based Therapy Regional Blood Center of Ribeirão Preto University of São Paulo Ribeirão Preto SP Brazil.

Keli Cristina Lima (KC)

Graduate Program in Biosciences Applied to Pharmacy School of Pharmaceutical Sciences of Ribeirão Preto University of São Paulo Ribeirão Preto SP Brazil.
Center for Cell-Based Therapy Regional Blood Center of Ribeirão Preto University of São Paulo Ribeirão Preto SP Brazil.

Juliana Bernardes Elias (JB)

Ribeirão Preto Medical School University of São Paulo São Paulo SP Brazil.

Ana Beatriz Pl Stracieri (ABP)

Ribeirão Preto Medical School University of São Paulo São Paulo SP Brazil.

Fabiano Pieroni (F)

Ribeirão Preto Medical School University of São Paulo São Paulo SP Brazil.

Renato Cunha (R)

Center for Cell-Based Therapy Regional Blood Center of Ribeirão Preto University of São Paulo Ribeirão Preto SP Brazil.
Ribeirão Preto Medical School University of São Paulo São Paulo SP Brazil.

Luiz Guilherme Darrigo-Júnior (LG)

Ribeirão Preto Medical School University of São Paulo São Paulo SP Brazil.

Carlos Eduardo Settani Grecco (CES)

Ribeirão Preto Medical School University of São Paulo São Paulo SP Brazil.

Dimas Tadeu Covas (DT)

Center for Cell-Based Therapy Regional Blood Center of Ribeirão Preto University of São Paulo Ribeirão Preto SP Brazil.
Ribeirão Preto Medical School University of São Paulo São Paulo SP Brazil.

Ana Cristina Silva-Pinto (AC)

Center for Cell-Based Therapy Regional Blood Center of Ribeirão Preto University of São Paulo Ribeirão Preto SP Brazil.
University Hospital of Ribeirão Preto Medical School University of São Paulo Ribeirão Preto SP Brazil.

Gil Cunha De Santis (GC)

Center for Cell-Based Therapy Regional Blood Center of Ribeirão Preto University of São Paulo Ribeirão Preto SP Brazil.
University Hospital of Ribeirão Preto Medical School University of São Paulo Ribeirão Preto SP Brazil.

Belinda Pinto Simões (BP)

Center for Cell-Based Therapy Regional Blood Center of Ribeirão Preto University of São Paulo Ribeirão Preto SP Brazil.
Ribeirão Preto Medical School University of São Paulo São Paulo SP Brazil.

Maria Carolina Oliveira (MC)

Center for Cell-Based Therapy Regional Blood Center of Ribeirão Preto University of São Paulo Ribeirão Preto SP Brazil.
Ribeirão Preto Medical School University of São Paulo São Paulo SP Brazil.

Antoine Toubert (A)

Université de Paris INSERM UMR 1160 IRSL Paris France.
Laboratoire d'Immunologie et d'Histocompatibilité Hôpital Saint-Louis AP-HP Paris France.

Kelen Cristina Ribeiro Malmegrim (KCR)

Center for Cell-Based Therapy Regional Blood Center of Ribeirão Preto University of São Paulo Ribeirão Preto SP Brazil.
Department of Clinical Analysis, Toxicology and Food Sciences School of Pharmaceutical Sciences of Ribeirão Preto University of São Paulo Ribeirão Preto SP Brazil.

Classifications MeSH